Skip to main content

Table 1 Clinical characteristics of 53 consecutive patients treated with CRS and HIPEC between February 2010 and March 2016 at our institution

From: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Patients All Primary CRS and HIPEC Secondary CRS and HIPEC (after PIPAC)
Number of patients 53 32 21
Age (years) 55.8 ± 9.5 55.3 ± 9.6 56.3 ± 9.5
Sex (M:F) 20:33 8:24 12:9
Karnofsky index (%) 86.0 ± 10.1 85.9 ± 11.0 92.1 ± 5.6
Organ
 -Ovarian 15 (28 %) 11 (35 %) 4 (19 %)
 -Colorectal/appendix 19 (36 %) 8 (25 %) 11 (52 %)
 -PMP 9 (17 %) 7 (22 %) 2 (10 %)
 -Gastric 6 (11 %) 3 (9 %) 3 (14 %)
 -Mesothelioma 4 (8 %) 3 (9 %) 1 (5 %)
Peritoneal Carcinomatosis index (initial PCI) 12 ± 8 13.3 ± 9.0 11.5 ± 6.4
Ascites (ml) 147 ± 466 0 ± 0 198 ± 536